Clinical Research Directory
Browse clinical research sites, groups, and studies.
Light Therapy in End Stage Kidney Disease
Sponsor: University of Pennsylvania
Summary
The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.
Official title: Bright Light Therapy to Treat Fatigue in End Stage Kidney Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-02-01
Completion Date
2026-08-01
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Bright light
Bright light treatment will consist of using the Re-timer device 3 times per week during dialysis sessions for 4 weeks. The Re-timer is worn like a pair of glasses and contains light emitting diodes mounted on the lower portion of the frame. The Re-timer emits blue-green 500 nm light with an intensity of \~500 lux lm/m2. Participants will be instructed to use the device for 60 minutes at the beginning of each dialysis session.
Dim Light
Dim light treatment will use non-light emitting glasses that look identical to Re-Timer for 4 weeks at each dialysis session following baseline assessments. Participants will use the device for 60 minutes at the beginning of their dialysis session.
Locations (1)
University of Pennsylvania
Philadelphia, Pennsylvania, United States